Evidence map · Neurofeedback · drug-resistant epilepsy
Neurofeedback for drug-resistant epilepsy: what the research shows
Neurofeedback (SMR/SCP) for drug-resistant epilepsy. 137 papers from 1973 to 2026, including 2 meta-analyses, 6 systematic reviews and 5 randomised controlled trials. Each study below links to its source.
137Papers in the corpus
2Meta-analyses
5Randomised controlled trials
7Open-access papers
Study design
Jev labels45 papers have no confident study-design label yet. Labels are AI-classified by Jev: advisory, not clinician-reviewed.
Papers over time
by publication year* 2025–26 is still in progress, so its count is incomplete.
Most-cited trials and reviews
by citations- 1
Meta-analysis of EEG biofeedback in treating epilepsy.
- 2
Neurofeedback impacts cognition and quality of life in pediatric focal epilepsy: An exploratory randomized double-blinded sham-controlled trial.
- 3
Biofeedback as complementary treatment in patients with epilepsy – an underestimated therapeutic option? Review, results, discussion
- 4
Comparison of the Effects of Sensorimotor Rhythm and Slow Cortical Potential Neurofeedback in Epilepsy
Decision support only. This page summarises published literature; it is not medical advice or a recommendation for any patient. Study designs and topic labels are AI-classified by Jev: advisory, not clinician-reviewed. Abstracts are not reproduced here: follow the links to read each source. Data snapshot 2026-09-25.